United States News Todas as matérias

U.S.-listed gold mining shares gained before the market opened as rising bullion prices lifted the sector, with spot gold reaching $4,377.32 per ounce.

The Ensign Group (NASDAQ:ENSG) declared a quarterly cash dividend of $0.0650 per share of common stock, payable on or before October 31, 2026.

Natera (NASDAQ:NTRA) presented new data from its Signatera molecular residual disease (MRD) test at the IASLC 2026 World Conference on Lung Cancer, including results from a 1,129-patient analysis in early-stage non-small cell lung cancer.

Nasdaq 100 futures led U.S. stock futures higher on Friday as declining oil prices reduced some inflation concerns and put the technology-focused index on track for weekly gains.

Brent crude and West Texas Intermediate oil prices declined for a third consecutive session as easing concerns over Saudi Arabian supply disruptions outweighed concerns about a wider Middle East conflict.

Nestlé said it is reviewing options after the Russian government placed its local business under temporary control through a presidential decree.

Taboola (NASDAQ:TBLA) announced an offer to acquire Dianomi, a digital advertising provider specializing in business, finance and lifestyle advertising.

Pearson (NYSE:PSO) acquired assessment technology provider ITS to strengthen its global assessment and verification capabilities.

W. P. Carey (NYSE:WPC) announced that its Board of Directors increased the quarterly cash dividend to $0.950 per share, representing an annualized dividend rate of $3.80 per share.

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) received authorization from Health Canada for their Omicron XFG-adapted COVID-19 vaccine.

Intuit (NASDAQ:INTU) provided fiscal 2027 guidance, expecting full-year revenue of $23.28 billion to $23.51 billion and first-quarter revenue of $4.29 billion to $4.31 billion.

Surgery Partners (NASDAQ:SGRY) updated its 2026 financial outlook following the completed sale of its Idaho Falls facilities to Intermountain Health.

Olenox Industries (NASDAQ:OLOX) reported that its CS Digital Ventures operations mined approximately 15.63 Bitcoin in August 2026 as the company continued operating its digital asset mining infrastructure.

MIRA Pharmaceuticals (NASDAQ:MIRA) submitted a Phase 2a clinical trial protocol for Ketamir-2 in chemotherapy-induced peripheral neuropathy (CIPN) following review and feedback from the U.S. Food and Drug Administration.

Applied Materials (NASDAQ:AMAT) announced plans to invest $5 billion in India over the next decade as the semiconductor equipment maker expands its presence in the country.

Atlanticus Holdings (NASDAQ:ATLC) completed the sale of its CAR Auto Finance operations for approximately $71.2 million, ending the company’s Auto Finance segment.

AtlasClear Holdings (NYSE:ATCH) expects preliminary fiscal 2026 revenue of approximately $20.1 million, up about 85% from $10.9 million in fiscal 2025, according to an update from the company.

Clearmind Medicine (NASDAQ:CMND) reported that its Chief of Global Impact Mary-Elizabeth Gifford participated in a U.S. Food and Drug Administration panel focused on potential future therapeutic use of psychedelic drugs.

S&P Global (NYSE:SPGI) agreed to acquire OpenZeppelin, a provider of onchain security standards and smart contract technology, in a transaction announced September 17, 2026.

Almonty Industries (NASDAQ:ALM) entered into a long-term tungsten concentrate supply agreement with Wolfram Bergbau und Hütten AG (WBH), a subsidiary of the Sandvik Group, covering tungsten recovery from existing tailings at the Los Santos Mine in western Spain.

Bank7 Corp. (NASDAQ:BSVN) agreed to acquire 100% of Century Financial Services Corporation, the parent company of Century Bank, under a definitive merger agreement announced September 17, 2026.

Nuvation Bio (NASDAQ:NUVB) received U.S. Food and Drug Administration approval for a supplemental New Drug Application updating efficacy information for IBTROZI (taletrectinib) in TKI-naïve adults with advanced ROS1-positive non-small cell lung cancer.

Bristol Myers Squibb (NYSE:BMY) reported positive two-year results from the Phase 3 POETYK PsA-2 study and its open-label extension, showing continued efficacy and a consistent safety profile for Sotyktu (deucravacitinib) in adults with active psoriatic arthritis.

AECOM (NYSE:ACM) announced that its Board of Directors declared a quarterly cash dividend of $0.31 per share as part of its ongoing dividend program.